Skip to content
About us
Mission
Strategy
Our story
Our team
Inobrodib
Science
Publications
Clinical trials
Indications under investigation
Current clinical trials
News
Press releases
Contact us
About us
Mission
Strategy
Our story
Our team
Inobrodib
Science
Publications
Clinical trials
Indications under investigation
Current clinical trials
News
Press releases
Contact us
Twitter
AACR, Atlanta, Elvin (2019)
p300/CBP inhibitor CCS1477 targets 22Rv1 prostate tumour AR and c-Myc gene expression
in vivo
.
Main Menu
About us
Mission
Strategy
Our story
Our team
Inobrodib
Science
Publications
Clinical trials
Indications under investigation
Current clinical trials
News
Press releases
Contact us
Follow us on Twitter